The coronavirus vaccine candidate being developed by Astrazeneca and Oxford University induces a strong immune response and is safe to use in humans, according to preliminary trial results.
The early stage trial has found that the vaccine causes few side effects and induces strong immune responses in both parts of the immune system – provoking a T cell response within 14 days of vaccination and an antibody response after 28 days.
More follows…
With inputs from independent.uk